0001752724-24-053441.txt : 20240313 0001752724-24-053441.hdr.sgml : 20240313 20240313141230 ACCESSION NUMBER: 0001752724-24-053441 CONFORMED SUBMISSION TYPE: N-CEN PUBLIC DOCUMENT COUNT: 3 CONFORMED PERIOD OF REPORT: 20231231 FILED AS OF DATE: 20240313 DATE AS OF CHANGE: 20240313 EFFECTIVENESS DATE: 20240313 FILER: COMPANY DATA: COMPANY CONFORMED NAME: VANGUARD VALLEY FORGE FUNDS CENTRAL INDEX KEY: 0000889519 ORGANIZATION NAME: IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: N-CEN SEC ACT: 1940 Act SEC FILE NUMBER: 811-58431 FILM NUMBER: 24745497 BUSINESS ADDRESS: STREET 1: P O BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 BUSINESS PHONE: 6106691000 MAIL ADDRESS: STREET 1: P.O. BOX 2600 STREET 2: V26 CITY: VALLEY FORGE STATE: PA ZIP: 19482 FORMER COMPANY: FORMER CONFORMED NAME: VANGUARD BALANCED INDEX FUNDS DATE OF NAME CHANGE: 20070223 FORMER COMPANY: FORMER CONFORMED NAME: VANGUARD BALANCED INDEX FUND DATE OF NAME CHANGE: 20011121 FORMER COMPANY: FORMER CONFORMED NAME: VANGUARD BALANCED INDEX FUND INC DATE OF NAME CHANGE: 19920715 0000889519 S000002560 VANGUARD BALANCED INDEX FUND C000007054 INVESTOR SHARES VBINX C000007055 ADMIRAL SHARES VBIAX C000007056 INSTITUTIONAL SHARES VBAIX 0000889519 S000019761 Vanguard Managed Allocation Fund C000055412 Investor Shares VPGDX 0000889519 S000075775 Vanguard Baillie Gifford Global Positive Impact Stock Fund C000235057 Investor Shares VBPIX 0000889519 S000082143 Vanguard Mid-Cap Index Fund C000245408 Admiral Shares VIMAX C000245409 ETF Shares VO C000245410 Investor Shares VIMSX C000245411 Institutional Shares VMCIX N-CEN 1 primary_doc.xml X0404 N-CEN LIVE 0000889519 XXXXXXXX 811-58431 true false false N-1A true VANGUARD VALLEY FORGE FUNDS 811-58431 0000889519 549300FUTH8HHBEZCJ03 100 Vanguard Boulevard Malvern 19355 US-PA US 6106691000 JPMorgan Chase Bank 383 Madison Avenue New York 10179 212-648-0466 The accounts, books, and other documents required to be maintained by Registrant pursuant to section 31(a) of the Investment Company Act of 1940 and the Rules thereunder. N N N-1A 2 Y F. Joseph Loughrey N/A N Deanna Mulligan N/A N Peter F. Volanakis N/A N Mark Loughridge N/A N Mortimer J. Buckley 002167630 Y Andre F. Perold N/A N Emerson U. Fullwood N/A N Sarah Bloom Raskin N/A N Scott C. Malpass N/A N David Thomas N/A N Tara Bunch N/A N Grant Reid N/A N Jacqueline Angell 005606776 100 Vanguard Boulevard Malvern 19355 XXXXXX N N N N N N VANGUARD MARKETING CORP. 8-21570 000007452 N/A Y N PRICEWATERHOUSECOOPERS LLP 000000238 5493002GVO7EO8RNNS37 N N N N N N N VANGUARD BAILLIE GIFFORD GLOBAL POSITIVE IMPACT STOCK FUND S000075775 549300H2IF21UEITQ770 N 1 0 0 N/A Y N N N N/A N/A N/A Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) N N N N Baillie Gifford Overseas Ltd 801-21051 000110296 549300OJXEENXLO4FW52 GB N The Vanguard Group, Inc. 084-00772 5493002789CX3L0CJP65 Y N N ITG Analytics Inc 41-2190282 TIN N Markit Group Limited 549300HLPTRASHS0E726 GB N JPMorgan Chase Bank 7H6GLXDRUGQFU57RNE97 N Markit North America INC 13-4153988 TIN N Refinitiv US LLC 20-4530702 TIN N ICE Data Pricing and Reference Data LLC 13-36687789 TIN N Bloomberg Finance LP 5493001KJTIIGC8Y1R12 N N The Bank of New York Mellon HPFHU0OQ28E4N0NFVK49 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) N The Vanguard Group, Inc. 5493002789CX3L0CJP65 Y N N THE VANGUARD GROUP, INC. 5493002789CX3L0CJP65 Y N State Street Bank and Trust Company 571474TGEMMWANRLN572 N Y N Macquarie Capital Securities (Singapore) Pte. Limited N/A N/A 5493007PKIT1P8UHLH29 SG 3531.69000000 Merrill Lynch International N/A 000162416 GGDZP1UYGU9STUHRDP48 GB 5602.79999999 BofA Securities, Inc. 008-69787 000283942 549300HN4UKV1E2R3U73 3018.41000000 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 7977.47000000 Credit Suisse Securities (Europe) Limited N/A N/A DL6FFRRLF74S01HE2M14 GB 2661.90000000 J.P. Morgan Securities PLC N/A N/A K6Q0W1PS1L1O4IQL9C32 GB 2338.02000000 DAIWA SECURITIES CO. LTD. N/A N/A 549300D405BPQ5DDVJ61 JP 3559.27000000 Morgan Stanley & Co. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 2284.07000000 Goldman Sachs International N/A N/A W22LROWP2IHZNBB6K528 GB 3537.22000000 JEFFERIES INTERNATIONAL LIMITED N/A N/A S5THZMDUJCTQZBTRVI98 GB 3639.40000000 56928.88999997 CLSA SINGAPORE PTE LTD N/A N/A 2138007HCL683ZPDD829 SG 5595389.42000000 Vanguard Market Liquidity Fund N/A N/A 1I6HV0TLSTR3A4XQ6L78 201554522.74000001 207149912.16000001 Y 227885034.83833333 Committed 4300000000.00000000 N N N N VANGUARD BALANCED INDEX FUND S000002560 YZYTHJ1EPVBIW2570X33 N 3 0 0 N N -0.03177999 -0.24338999 0.76710088 0.76685197 N N Y N N The Vanguard Group, Inc. 5493002789CX3L0CJP65 Y N Administrative fee Cash collateral reinvestment fee 68919645.15999999 6509633.95000000 Rule 17a-7 (17 CFR 270.17a-7) Rule 18f-4(f)(17 CFR 270.18f-4(f)) Rule 32a-4 (17 CFR 270.32a-4) Rule 18f-4(c)(4) (17CFR 270.18f-4(c)(4)) N N N N The Vanguard Group, Inc. 801-11953 000105958 5493002789CX3L0CJP65 N The Vanguard Group, Inc. 084-00772 5493002789CX3L0CJP65 Y N N JPMorgan Chase Bank 7H6GLXDRUGQFU57RNE97 N ICE Data Pricing and Reference Data LLC 13-36687789 TIN N Markit North America INC 13-4153988 TIN N ITG Analytics Inc 41-2190282 TIN N Refinitiv US LLC 20-4530702 TIN N Bloomberg Finance LP 5493001KJTIIGC8Y1R12 N Markit Group Limited 549300HLPTRASHS0E726 GB N N J.P. MORGAN SE - LUXEMBOURG BRANCH 549300ZK53CNGEEI6A29 FR N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) J.P. MORGAN SE - LUXEMBOURG BRANCH 549300ZK53CNGEEI6A29 NL N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Euroclear 549300OZ46BRLZ8Y6F65 BE N Y Foreign securities depository - rule 17f-7 (17 CFR 270.17f-7) JPMorgan Chase Bank NA 7H6GLXDRUGQFU57RNE97 N N Bank - section 17(f)(1) (15 U.S.C. 80a-17(f)(1)) BNP Paribas Securities Services SCA R0MUWSFPU8MPRO8K5P83 IT N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) J.P. MORGAN SE - LUXEMBOURG BRANCH 549300ZK53CNGEEI6A29 BE N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Royal Bank of Canada ES7IP3U3RHIGC71XBU11 CA N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) Skandinaviska Enskilda Banken AB (publ) F3JS33DEI6XQ4ZBPTN86 FI N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) JPMorgan Chase Bank NA 7H6GLXDRUGQFU57RNE97 GB N Y Foreign custodian - rule 17f-5 (17 CFR 270.17f-5) N The Vanguard Group, Inc. 5493002789CX3L0CJP65 Y N N JPMORGAN CHASE BANK, N.A. 7H6GLXDRUGQFU57RNE97 N Y THE VANGUARD GROUP, INC. 5493002789CX3L0CJP65 Y N N BofA Securities, Inc. 008-69787 000283942 549300HN4UKV1E2R3U73 60718.72999999 Mizuho Securities USA Inc 008-37710 000019647 5493004GRDTUI7EMIZ82 22591.33000000 CITIGROUP INC. N/A N/A 6SHGI4ZSSLCXXQSBB395 168072.11999999 Virtu Americas LLC 008-68193 000149823 549300RA02N3BNSWBV74 10308.49000000 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 51232.58000000 RBC Capital Markets, LLC 008-45411 000031194 549300LCO2FLSSVFFR64 5287.46000000 Barclays Capital Inc. 008-41342 000019714 AC28XWWI3WIBK2824319 55705.36000000 Goldman Sachs & Co. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 30640.72999999 JonesTrading Institutional Services LLC 008-26089 000006888 2138008JJ5PA8H5UIL69 5414.65000000 Morgan Stanley & Co. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 54554.00000000 485021.58999991 Deutsche Bank Securities Inc. 008-17822 000002525 9J6MBOOO7BECTDTUZW19 606129217.82000012 CITIGROUP INC. N/A N/A 6SHGI4ZSSLCXXQSBB395 1234128290.53999949 Goldman Sachs & Co. LLC 008-00129 000000361 FOR8UP27PHTHYVLBNG30 3060682164.90000325 Vanguard Market Liquidity Fund N/A N/A 1I6HV0TLSTR3A4XQ6L78 8986603515.23999980 Barclays Capital Inc. 008-41342 000019714 AC28XWWI3WIBK2824319 886377086.92999945 J.P. Morgan Securities LLC 008-35008 000000079 ZBUT11V806EZRVTWT807 1701039274.45999841 Citadel Securities LLC 008-53574 000116797 12UUJYTN7D3SW8KCSG25 533034558.43999988 Morgan Stanley & Co. LLC 008-15869 000008209 9R7GPTSO7KV3UQJZQ078 2945599622.19000067 BofA Securities, Inc. 008-69787 000283942 549300HN4UKV1E2R3U73 1563483320.87000598 Wells Fargo Securities, LLC 008-22947 000007665 VYVVCKR63DVZZN70PB21 1228201197.20000021 26842889827.70000664 N 49435542136.92583333 Committed 4300000000.00000000 N N N N true INTERNAL CONTROL RPT 2 valleyforgefunds2.16.txt Report of Independent Registered Public Accounting Firm To the Board of Trustees of Vanguard Valley Forge Funds and Shareholders of Vanguard Balanced Index Fund In planning and performing our audit of the financial statements of Vanguard Balanced Index Fund (one of the funds constituting Vanguard Valley Forge Funds, referred to hereafter as the "Fund") as of and for the year ended December 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2023. This report is intended solely for the information and use of the Board of Trustees of Vanguard Valley Forge Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/ PricewaterhouseCoopers LLP Philadelphia, Pennsylvania February 16, 2024 INTERNAL CONTROL RPT 3 valleyforgefunds2.15.txt Report of Independent Registered Public Accounting Firm To the Board of Trustees of Vanguard Valley Forge Funds and Shareholders of Vanguard Baillie Gifford Global Positive Impact Stock Fund In planning and performing our audit of the financial statements of Vanguard Baillie Gifford Global Positive Impact Stock Fund (one of the funds constituting Vanguard Valley Forge Funds, referred to hereafter as the "Fund") as of and for the year ended December 31, 2023, in accordance with the standards of the Public Company Accounting Oversight Board (United States) (PCAOB), we considered the Fund's internal control over financial reporting, including controls over safeguarding securities, as a basis for designing our auditing procedures for the purpose of expressing our opinion on the financial statements and to comply with the requirements of Form N-CEN, but not for the purpose of expressing an opinion on the effectiveness of the Fund's internal control over financial reporting. Accordingly, we do not express an opinion on the effectiveness of the Fund's internal control over financial reporting. The management of the Fund is responsible for establishing and maintaining effective internal control over financial reporting. In fulfilling this responsibility, estimates and judgments by management are required to assess the expected benefits and related costs of controls. A company's internal control over financial reporting is a process designed to provide reasonable assurance regarding the reliability of financial reporting and the preparation of financial statements for external purposes in accordance with generally accepted accounting principles. A company's internal control over financial reporting includes those policies and procedures that (1) pertain to the maintenance of records that, in reasonable detail, accurately and fairly reflect the transactions and dispositions of the assets of the company; (2) provide reasonable assurance that transactions are recorded as necessary to permit preparation of financial statements in accordance with generally accepted accounting principles, and that receipts and expenditures of the company are being made only in accordance with authorizations of management and directors of the company; and (3) provide reasonable assurance regarding prevention or timely detection of unauthorized acquisition, use or disposition of a company's assets that could have a material effect on the financial statements. Because of its inherent limitations, internal control over financial reporting may not prevent or detect misstatements. Also, projections of any evaluation of effectiveness to future periods are subject to the risk that controls may become inadequate because of changes in conditions, or that the degree of compliance with the policies or procedures may deteriorate. A deficiency in internal control over financial reporting exists when the design or operation of a control does not allow management or employees, in the normal course of performing their assigned functions, to prevent or detect misstatements on a timely basis. A material weakness is a deficiency, or a combination of deficiencies, in internal control over financial reporting, such that there is a reasonable possibility that a material misstatement of the company's annual or interim financial statements will not be prevented or detected on a timely basis. Our consideration of the Fund's internal control over financial reporting was for the limited purpose described in the first paragraph and would not necessarily disclose all deficiencies in internal control over financial reporting that might be material weaknesses under standards established by the PCAOB. However, we noted no deficiencies in the Fund's internal control over financial reporting and its operation, including controls over safeguarding securities, that we consider to be a material weakness as defined above as of December 31, 2023. This report is intended solely for the information and use of the Board of Trustees of Vanguard Valley Forge Funds and the Securities and Exchange Commission and is not intended to be and should not be used by anyone other than these specified parties. /s/ PricewaterhouseCoopers LLP Philadelphia, Pennsylvania February 15, 2024